Menu
Your Cart

Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12

Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12
$524.87
  • Stock: In Stock
  • Model: 176197

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Kopakson the 40th solution for infection. 40mg/ml syringe of 1 ml No. 12

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Kopakson 40 is shown for treatment of recurrent forms of multiple sclerosis.

Kopakson 40 is not appointed at initially or the secondary progressing multiple sclerosis.

Structure

Active ingredient: glatiramer acetate;

for injections 40 mg of a glatiramer of acetate contain

1 ml of solution;

Excipients: a mannitol (E 421), water for injections.

Contraindication

Hypersensitivity to medicine components.

Route of administration

For adults the recommended dose makes 40 mg of a glatiramer of acetate (one previously filled syringe) entered subcutaneously 3 times a week. The break between injections has to make at least 48 hours. It is recommended to use medicament in the same days every week.

Now treatment duration Kopakson 40 is not established to

.

Decision on duration of treatment is made by the doctor individually for each case.

Feature of application

Pregnant

as a measure of restraint it is desirable for p to avoid use of medicine during pregnancy, except for cases when the advantage of application for mother exceeds risk of potential impact on a fruit.

Children

should not apply Kopakson the 40th this age category.

to

Overdose

by

It was reported about several cases of overdose by Kopakson (at application of 300 mg of a glatiramer of acetate).

Side effects

Reaction in the injection site that were most often observed at use of medicine of Kopakson-Tev in a dose of 20 mg/ml in comparison with placebo, were included by an erythema, pain, new growths, an itch, hypostasis, inflammation and hypersensitivity.

by

Interaction

observed the increased frequency of reactions in the injection site of the medicine Kopakson 40. It was reported about increase in frequency of local reactions at the patients receiving therapy by corticosteroids.

Storage conditions

to Store

in original packing for protection against light at a temperature of 2 °C - 8 °C (in the fridge). Not to freeze.

to Store

out of children's reach.

If does not have

an opportunity to store the filled syringes in the fridge, then they can be stored at a temperature of 15 °C - 25 °C no more than 1 month.

If after this term in one month did not fill syringes with Kopakson solution 40 are used and are in original packing, then they need to be stored in the fridge at a temperature of 2 °C - 8 °C.

Expiration date - 2 years.

Specifications

Characteristics
Active ingredients Glatiramera acetate
Amount of active ingredient 40 mg/ml
Applicant Teva
Code of automatic telephone exchange L03AX13 Glatiramer acetate
Interaction with food It doesn't matter
Light sensitivity Sensitive
Market status Original
Origin Chemical
Prescription status According to the prescription
Primary packing syringe
Producer TEVA PHARMATSEVTIKAL INDUSTRIES LTD
Quantity in packing 12 pieces.
Release form solution for injections
Route of administration Intramuscular
Sign Import
Storage temperature from 2 °C to 8 °C
Trade name Kopakson